Avatar 1Avatar 2Avatar 3Avatar 4Avatar 5

Earn 10$ Cash for every Pro+ Friend you Refer!

Cerevel Therapeutics Holdings Inc
delisted

Cerevel Therapeutics Holdings Inc

CERE · NASDAQ
CERE · NASDAQ
44.96
USD0.330.74%

222 Jacobs Street, Cambridge, MA, United States, 02141

Full Time Employees

355

GIC Sector

Health Care

GIC Group

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Top executives

Name

Title

Year Born

Dr. N. Anthony Coles Jr., M.P.H.

Executive Chairman

1960

Mr. Ronald C. Renaud Jr., M.B.A.

President, CEO & Director

1969

Dr. Susan Altschuller M.B.A., Ph.D.

Chief Financial Officer

1982

Mr. Mark Bodenrader

Senior VP of Finance & Chief Accounting Officer

1973

Dr. John J. Renger Ph.D.

Chief Scientific Officer

1969

Dr. Ramiro Sanchez M.D.

Chief Medical Officer

1961

Mr. Paul D. Burgess J.D.

Chief Business Development & Strategic Operations Officer

1974

Mr. Matthew Calistri

Vice President of Investor Relations

-

Mr. Scott M. Akamine J.D.

Chief Legal Officer & Corporate Secretary

1985

Mr. Kenneth A. DiPietro

Chief Human Resources Officer

1959

FAQs

What is Cerevel Therapeutics Holdings stock price today?

What is Cerevel Therapeutics Holdings stock ticker?

Is CERE stock price going up?

What is the analyst recommendation for CERE?

What is CERE market cap?

Does CERE release financial reports?

When is CERE next earnings date?

What were CERE Earnings for the last quarter?

What was CERE Revenue for the last quarter?

What was CERE Net Income for the last quarter?

Does CERE pay dividends?

How many employees does CERE have?

What is CERE EBITDA?

How to buy CERE stocks?

Should I invest in CERE stock?